Advanced Nurse Practitioner and Certified Nurse Midwife
Highly focused and knowledgeable professional with experience in providing a Full spectrum of excellent Women‘s health care within a private clinic and hospital setting. Provide primary and specialty care for women, diagnosing, trying, and managing the care of women with acute and chronic illnesses. HPV screening and vaccinations. Conducting physical examinations and interpreting medical history, ordering and managing care based on diagnostic tests and procedures. Delivering babies and attend ing to pregnancy-related issues. Providing care to women from puberty through menopause, including newborn care. Prescribing pharmacologic treatment. Counseling and educating clients Practices in collaboration with obstetricians & Gynecologists.
Previous Registered Nurse
Highly skilled career professional with 19 years of practical experience in Labor Delivery on a moderate to high-risk unit intermittent charge nurse position that facilitates a safe work environment, liaison between nurses and physicians and serves as a link in the chain of command Manages maternal and fetal status from admission to postpartum Cross-trained for OB Operating Room Surgical Scrub Technician Preceptor for new perinatal nurses Proficient in collaboration with a multidisciplinary team to provide all aspects of perinatal care Consistent recipient of Palmetto General Hospital ‘s Honor Roll Labor and Delivery Nurse of the Year at Palmetto General Hospital 2007.
CREDENTIALS
• Licensed and Board Certified Advanced Registered Nurse Practitioner and Certified Nurse Midwife, January 2013
• Permanent Florida License ARNP 2729712
• Basic Life Support (BLS) Ce1tified
• Advanced Cardiac Life Support (ACLS) Ce1tified
• Neonatal Resuscitation Provider (NRP) Certified
• Advanced Fetal Monitoring Certified
• Certified Biomedical Researcher for Cord Use public cord banking
• Certified in Vaginal & Cervical Colposcopy
• National Provider Identifier (NPI) 1346681202
• Certified Research Coordinator
EXPERIENCE
2016 – Present – Doral Medical Research, LLC
2015 – 2016 – Universal Clinical Research Associates
3/2013 – Present – Dr. Victoria Garcia & Associates Advanced Registered Nurse Practitioner Certified Nurse Midwife
8/2012-3 /2 013 – Memorial Miramar Hospital, Miramar , Florida Registered Nurse
6/1993-3/2013 – Palmetto General Hospital, Hia leah, F lorid a Regist e red Nurse
EDUCATION
8/2010-3/2012 – Frontier Nursing University Hyden, Kentucky Masters in Advanced Registered Nurse Practice Masters in Midwifery
1/2009-1/2010 – University of Phoenix (Online Education) Phoenix, Arizona Masters in Nursing Administration
8/2008-6/2009 – Nova Southeastern University Davie, Florida Bachelor of Science in Nursing
8/1990 -6/1993 – Miami Dade Community College Miami, Florida Associates of Science in Nursing
9/1986-6/1989 – Norland Senior High School Miami, Florida High School Diploma
HOSPITAL
Palmetto General Hospital
RESEARCH CERTIFICATIONS /TRAININGS: NIH GCP Certification (CITI program)
CLINICAL RESEARCH
Sub Investigator
Bayer Pharmaceuticals: A randomized, parallel-group, double-blind and open-label, placebo-controlled, multicenter study to assess the efficacy and safety of XXXXX in subjects with uterine fibroids. 2018
Myovant Sciences: An international Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate XXXXX Co–Administered with ad without Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids. 2017
Bayer Pharmaceuticals: An open–label, parallel-group, randomized, multicenter study to assess the safety and efficacy of XXXXX in subjects with uterine fibroids versus standard of care. 2017 NCT03194646
AbbVie: Phase III Fibroid Study; Menstrual flow research to XXX medication versus Placebo 01/2016
Merck Sharp & Dohme Corp: A Phase 2a, Proof of Concept, Randomized, Double–blind Placebo-controlled Clinical Trial, to Evaluate the Efficacy and Safety of MK7264 in Women with Moderate to Severe Endometriosis-related Pain. 2018
Janssen Pharmaceuticals: A Randomized, Double-blind, Placebo-controlled, First-in-Human, Phase l/2a/2b Study to Evaluate Safety, Reactogenicity, Regimen Immunogenicity and Efficacy of Monovalent HPV16 and HPVl 8 Ad26-vectored Vaccine Components and an MVA-vectored HPV16/18 Vaccine Component in Otherwise Healthy Women with Persistent HPV16 or 18 Infection of the Cervix. 2019